Literature DB >> 1719372

Regulation of the oncogenic activity of the cellular src protein requires the correct spacing between the kinase domain and the C-terminal phosphorylated tyrosine (Tyr-527).

B S Cobb1, D M Payne, A B Reynolds, J T Parsons.   

Abstract

Repression of the tyrosine kinase activity of the cellular src protein (pp60c-src) depends on the phosphorylation of a tyrosine residue (Tyr-527) near the carboxy terminus. Tyr-527 is located 11 residues C terminal from the genetically defined end of the kinase domain (Leu-516) and is therefore in a negative regulatory region. Because the precise sequence of amino acids surrounding Tyr-527 appears to be unimportant for regulation, we hypothesized that the conformational constraints induced by phosphorylated Tyr-527 may require the correct spacing between the kinase domain (Leu-516) and Tyr-527. In this report, we show that deletions at residue 518 of two, four, or seven amino acids or insertions at this residue of two or four amino acids activated the kinase activity and thus the transforming potential of pp60c-src. As is the case for the prototype transforming variant, pp60527F, activation caused by these deletions or insertions was abolished when Tyr-416 (the autophosphorylation site) was changed to phenylalanine. In comparison with wild-type pp60c-src, the src proteins containing the alterations at residue 518 showed a lower phosphorylation state at Tyr-527 regardless of whether residue 416 was a tyrosine or a phenylalanine. Mechanisms dealing with the importance of spacing between the kinase domain and Tyr-527 are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719372      PMCID: PMC361728          DOI: 10.1128/mcb.11.12.5832-5838.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Deletions and insertions within an amino-terminal domain of pp60v-src inactivate transformation and modulate membrane stability.

Authors:  H C Wang; J T Parsons
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

2.  Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain.

Authors:  C A Cartwright; W Eckhart; S Simon; P L Kaplan
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

3.  Features of the pp60v-src carboxyl terminus that are required for transformation.

Authors:  P Yaciuk; D Shalloway
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

4.  Activation of the cellular src gene by transducing retrovirus.

Authors:  S Ikawa; K Hagino-Yamagishi; S Kawai; T Yamamoto; K Toyoshima
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Stable association of activated pp60src with two tyrosine-phosphorylated cellular proteins.

Authors:  A B Reynolds; S B Kanner; H C Wang; J T Parsons
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

7.  Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation.

Authors:  T E Kmiecik; D Shalloway
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

8.  Src homology 2 domain deletion mutants of p60v-src do not phosphorylate cellular proteins of 120-150 kDa.

Authors:  P A Wendler; F Boschelli
Journal:  Oncogene       Date:  1989-02       Impact factor: 9.867

9.  Site-specific increased phosphorylation of pp60v-src after treatment of RSV-transformed cells with a tumor promoter.

Authors:  A F Purchio; M Shoyab; L E Gentry
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

10.  Rous sarcoma virus variants that encode src proteins with an altered carboxy terminus are defective for cellular transformation.

Authors:  V W Wilkerson; D L Bryant; J T Parsons
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

View more
  7 in total

1.  Quantitative relation between intermolecular and intramolecular binding of pro-rich peptides to SH3 domains.

Authors:  Huan-Xiang Zhou
Journal:  Biophys J       Date:  2006-08-04       Impact factor: 4.033

2.  Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK.

Authors:  B S Cobb; M D Schaller; T H Leu; J T Parsons
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

3.  Regulation of c-SRC activity and function by the adapter protein CAS.

Authors:  M R Burnham; P J Bruce-Staskal; M T Harte; C L Weidow; A Ma; S A Weed; A H Bouton
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

4.  Overexpression and significance of focal adhesion kinase in hepatocellular carcinoma and its relationship with HBV infection.

Authors:  Lei Cai; Juan Han; Xianlu Zhuo; Yan Xiong; Jiahong Dong; Xiaowu Li
Journal:  Med Oncol       Date:  2008-11-20       Impact factor: 3.064

5.  Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src.

Authors:  G Superti-Furga; S Fumagalli; M Koegl; S A Courtneidge; G Draetta
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

6.  The mitogen-activated protein kinase p38α regulates tubular damage in murine anti-glomerular basement membrane nephritis.

Authors:  Ralf Müller; Christoph Daniel; Christian Hugo; Kerstin Amann; Dirk Mielenz; Karlhans Endlich; Tobias Braun; Betty van der Veen; Peter Heeringa; Georg Schett; Jochen Zwerina
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

7.  A p130Cas tyrosine phosphorylated substrate domain decoy disrupts v-crk signaling.

Authors:  Kathrin Kirsch; Margaret Kensinger; Hidesaburo Hanafusa; Avery August
Journal:  BMC Cell Biol       Date:  2002-07-15       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.